about
A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitisUpper airway inflammation in waste handlers exposed to bioaerosols.Gastric asthma: an unrecognized disease with an unsuspected frequency.A comparison of the clinical efficacy and safety of intranasal fluticasone propionate and antihistamines in the treatment of rhinitis.Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland.Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthmaFexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Installation of mechanical ventilation in a horse stable: effects on air quality and human and equine airways.Serum eosinophilic cationic protein may predict clinical course of wheezing in young childrenPeripheral blood lymphocyte subpopulations in schoolchildren born very pretermIntranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.The burden of allergic rhinitis and asthma.The Antiinflammatory Properties of Humic Substances: A Mini Review.Olopatadine nasal spray for the treatment of allergic rhinitis.Effect of acupuncture in the treatment of seasonal allergic rhinitis: a randomized controlled clinical trial.Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study.ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France.Inflammatory markers in childhood asthma.Influence of horse stable environment on human airways.Safety of a Novel Botanical Extract Formula for Ameliorating Allergic rhinitis. Part II.Nasal lavage biomarkers: effects of water damage and microbial growth in an office building.Preliminary results of a pilot study investigating the potential of salivary cortisol measurements to detect occult adrenal suppression secondary to steroid nose drops.Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents.Treating allergic rhinitis and asthma: different sides of the same fence.A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).Atypical nasal challenges in patients with idiopathic rhinitis: more evidence for the existence of allergy in the absence of atopy?[Allergic rhinitis: burden of disease].The prevalence of allergic diseases and atopy in Ankara, Turkey: a two-step population-based epidemiological study.Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy.Chronic rhinosinusitis in allergic asthmatic patients: radiography versus low-dose computed tomography evaluation.The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites.Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients.Functional morphology of nasal blood vessels in humans.Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation.A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitisTreatment of Allergic Rhinitis
P2860
Q28307749-DEA1E3EC-DDB5-4625-AD35-E8DFE417A8DFQ30496321-F9D2D25D-12DB-4407-BE08-14DC159BF0BCQ33674098-99A66328-AE95-490D-B3B1-E11C3B9F9EACQ33993551-CE6054C3-D526-495B-8BD7-D4F772D42C62Q34778060-D2134897-5C17-4883-A54E-3C2AB5A62757Q34800047-18C7EE52-D40B-4AD6-85C7-ADF7453E54E8Q34988193-3A95731B-2A5D-4E49-A93D-D05AB5DBD962Q35051396-11511542-573B-4EB2-9F32-AA0E025DC968Q35259353-9D9D0D60-5A26-4303-ADCD-E3A8D74A4C71Q35288734-BAF35ED4-CB01-4A10-81E9-3E1B4C65212DQ36985924-B3E12EEB-4516-488C-B828-F8FBBFD6FE57Q37969671-096F1142-171E-4C0D-9D06-5DE142701DDCQ38366835-1044478C-1173-4726-B6AC-6F263D2E49B1Q39287465-BA81CEDA-B5E3-4B63-8A90-AD96E96D6C85Q39406031-F6D9AE64-3042-4083-931C-90CC78229B86Q39417524-09A759DE-CCDC-4E16-B6D5-2742A2A45576Q39463230-B3BB71AB-4A11-496D-9D70-2DC52C01F6B2Q39603580-CDEB086B-0883-4AD9-A9F6-60B8EC8732E5Q41250324-D8BA6787-48A7-44E2-A279-D92FC1018B6CQ43115348-A52643DB-C222-47DF-8DA8-E341392FB676Q43215627-A56196F4-9F42-4A7D-A308-5483740D0525Q43546530-96F5602E-99BD-47ED-A549-27D27DF3EB4CQ43662160-9F4242BA-E2B7-42FE-B022-4CA778E0878BQ43818308-0C18496F-D0A4-4D9E-9048-1D0642B6179FQ43836540-C1172055-8925-4191-9EF7-F31232D2A349Q43987754-BE8EF88E-F6E9-4A7C-A569-E9434F082BA3Q44167428-46B75EF6-9F0B-4211-B333-83B1EC91D6DDQ44173538-74B449DB-B171-4FA9-9F6B-B10DF980FDF1Q44436597-F7417AB8-FE0A-4AB8-BA55-696E8F7AC9EDQ45217246-05D953D3-44C5-40D8-B9FC-39A51E43696BQ46619347-842D883A-AC5E-40F5-9EC2-AE5FC4EB7DF9Q46677716-7862612C-428E-475F-A25C-F4950273AE03Q46743209-5D4329F4-1B81-4B95-B66D-2DA99374DE1CQ48650274-983138F3-1657-4FF7-B3D9-466412C9195AQ53340561-6B22D403-9A34-4473-8427-E0BE2115D764Q54450053-D9BFE761-6099-4D70-99B3-5F399755E252Q54746716-16A5346F-FF6A-40F7-A375-E68EAED3A448Q57480654-3B1C0286-894C-4B2D-8E10-DA8FB1B36779Q58289635-36BB956E-E098-4359-B45A-CF6C8868EF7A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Soluble markers of allergic inflammation.
@en
type
label
Soluble markers of allergic inflammation.
@en
prefLabel
Soluble markers of allergic inflammation.
@en
P2860
P1433
P1476
Soluble markers of allergic inflammation.
@en
P2093
P2860
P356
10.1111/J.1398-9995.1994.TB00765.X
P577
1994-01-01T00:00:00Z